CRG30 Aug 2012 22:55
"The next phase is to roll out our new Unity knee system. The knees market is growing faster than the hips market, and this presents a big opportunity for us," Huntley said, adding that "knees are really the story from 2013".
For the time being, however, sales of Knees products are in the shadow of Hips, with first half 2012 sales down 5% to £3.5m from £3.7m.
Geographically, the group saw the top line dip in its biggest market, Australia, but otherwise it saw sales growth in all of its regions, including the key US market.
The 10% decline in sales in Australia to £5.6m was not altogether a surprise, Huntley explained, as previously the company had enjoyed good sales of LARS ligament augmentation products down under, whereas sales have dropped off as Aussie health-care professionals debate the validity of the use of LARS in anterior cruciate ligament surgery.
That decline, along with the fact that Mako will not be placing any orders in the second half after completing its restocking initiative. has persuaded management to take a cautious view of the rest of the year, with sales likely to be down year-on-year.
Another factor that has caught the attention of the bears is the threat of litigation relating to Corin's legacy metal-on-metal (MoM) products.